REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Neopharma Biotech Asia Sdn. Bhd. (Malaysia)

Main Activities: Other Chemical and Allied Products Merchant Wholesalers
Full name: Neopharma Biotech Asia Sdn. Bhd. Profile Updated: January 24, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2024 Available in: English Download a sample report

Neopharma Biotech Asia Sdn. Bhd. is a company in Malaysia, with a head office in Petaling Jaya. It operates in the Other Chemical and Allied Products Merchant Wholesalers sector. Neopharma Biotech Asia Sdn. Bhd. was incorporated on April 07, 2004. The company’s latest financial report indicates a net sales revenue drop of 93.34% in 2024. Over the same period, its total assets grew by 53.17%.

Headquarters
Unit B-G-3 Boulevard 51, Jalan 51A/241, Seksyen 51A
Petaling Jaya; Selangor; Postal Code: 46100

Contact Details: Purchase the Neopharma Biotech Asia Sdn. Bhd. report to view the information.

Website: http://www.neopharmaasia.com

Basic Information
Financial Auditors:
Purchase the Neopharma Biotech Asia Sdn. Bhd. report to view the information.
Incorporation Date:
April 07, 2004
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
51%
Purchase this report to view the information.
48%
Purchase this report to view the information.
1%
Company Performance
Financial values in the chart are available after Neopharma Biotech Asia Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-93.34%▼
Total Operating Revenue
-93.34%▼
Operating Profit
N/A
EBITDA
N/A
Net Profit/Loss for the Period
N/A
Total Assets
53.17%▲
Total Equity
16.3%▲
Operating Profit Margin
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-1.08%▼

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo